Want to be part of a bold new project, a public-led fun online clinical trial? Here it is - The People's Trial.
Robert Walton blogs Cochrane evidence on interventions to support clinical guideline implementation.
School children in Ireland have run and presented their own randomised trials in the innovative START (Schools Teaching About Randomised Trials) competition. Here's what they achieved and why this matters.
In this blog for our Understanding Evidence series, Emma Carter and Selena Ryan-Vig share resources to help you get to grips with some key concepts that can help us to think critically about treatment claims.
Cochrane Crowd's Community Engagement and Partnerships Manager Emily Steele, and Co-Leader Anna Noel-Storr blog about the benefits for students of getting involved with Cochrane Crowd, Cochrane's citizen science platform.
This is a transcript of a podcast interview with Gregor Smith, general practitioner and Deputy Chief Medical Officer of Scotland, conducted by Casey Quinlan @MightyCasey. Recorded at the Cochrane Colloquium 2018 .
Richard Lehman, Professor of the Shared Understanding of Medicine at the University of Birmingham, reflects on the latest Cochrane evidence on shared decision making
Opeyemi Babatude, Research Associate at Keele University, introduces “Evidence Flowers” as a novel way of providing a visual summary of research evidence.
Sandra Galvin and Shaun Treweek blog about the START competition that challenges children in Ireland's primary schools to become trialists and reflects on what they have achieved.
Nurse Helen Cowan delves into the Cochrane Library to explore some 'known unknowns', and reflects on what practitioners might do when the evidence is equivocal, and what might bridge the evidence gap.
Shaun Treweek points a finger at the thin evidence base for trial process decision-making and highlights a new funding initiative from the National Institute for Health Research that will help.
Katie Gillies and Derek Stewart, from the PRioRiTy II group, highlight the need for the identification of a national research agenda on retention to clinical trials developed and prioritised by all relevant stakeholders.